Request a Call Back
Please contact us for any questions or concerns regarding our products.
ADT Biotech +60 3 7931 6760
ADT India +91 11 4904 1337
ADT Korea +82 31 8058 0301
SDT Molecular +65 8323 6002
LyteStar™ Detection Kits
LyteStar™ Detection Kits are developed in compliance with ISO 13485 for emerging needs and specific customer requirements in ADT’s home markets.
Dual target assay for detection of SARS-related Coronaviruses (E-gene) and specific detection of Novel (“Wuhan”) Coronavirus 2019-nCoV (RdRP-gene).
Accurate typing of Hepatitis C Virus (HCV) Genotypes 1, 1a, 1b, 2, 3, 4, 5, and 6 by real-time PCR.
Specific detection of HIV-2 RNA (subtypes A and B) without cross-reactivity for HIV-1.
Specific detection of pathogenic Leptospira species without cross-reactivity for non-pathogenic / saprophytic species.
Specific detection of Orientia tsutsugamuchi, the bacteria causing Scrub Typhus.
For detection and differentiation of Mycobacterium tuberculosis complex and non-tuberculous mycobacteria (NTM).
The LyteStar™ TB/NTM Kit was clinically evaluated against mycobacteria culture in a study at the Korea University Hospital. The evaluation of the clinical sensitivity was performed with 129 specimens and the evaluation of clinical specificity was conducted with an additional 99 specimens. Results were achieved by comparing the results obtained with the LyteStar™ TB/NTM Kit against results obtained by mycobacteria culture for the individual specimen. Specimens with discrepant results between culture and the LyteStar™ TB/NTM Kit were resolved by review of the patient’s clinical records. Results are summarized below.